You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK)及多家下屬企業通過高新技術企業認定
格隆匯 05-13 16:52

格隆匯5月13日丨白雲山(00874.HK)發佈公吿,近日,公司及司屬企業廣州白雲山敬修堂藥業股份有限公司、廣州白雲山星羣(藥業)股份有限公司、廣州白雲山天心製藥股份有限公司、廣州白雲山明興製藥有限公司、廣州白雲山漢方現代藥業有限公司、廣州白雲山奇星藥業有限公司、廣州白雲山中一藥業有限公司、廣州王老吉藥業股份有限公司、廣州白雲山潘高壽藥業股份有限公司、廣州白雲山陳李濟藥廠有限公司、廣州醫藥信息科技有限公司共12家企業已分別順利通過了高新技術企業認定,並分別收到由廣東省科學技術廳、廣東省財政廳、國家税務總局廣東省税務局聯合頒發的《高新技術企業證書》。

上述企業通過高新技術企業認定後,根據國家相關規定,自獲得高新技術企業認定連續三年內(2020年、2021年和2022年)可享受國家關於高新技術企業的相關優惠政策,即按15%的税率繳納企業所得税。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account